How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
10
HBIO Quote, Financials, Valuation and Earnings
Last price:
$0.39
Seasonality move
:
-3.11%
Day range:
$0.36 - $0.40
52-week range:
$0.36 - $4.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.17x
P/B ratio:
0.25x
Volume:
407.6K
Avg. volume:
389.3K
1-year change:
-90.16%
Market cap:
$16.1M
Revenue:
$94.1M
EPS (TTM):
-$0.29
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Revenue Growth (YoY) | -12.12% | 16.46% | -4.68% | -0.96% | -16.14% | |
| Cost of Revenues | $44.1M | $51.3M | $52.5M | $46.2M | $39.4M | |
| Gross Profit | $58M | $67.7M | $60.8M | $66.1M | $54.8M | |
| Gross Profit Margin | 56.85% | 56.9% | 53.66% | 58.86% | 58.18% | |
| R&D Expenses | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | |
| Selling, General & Admin | $43.4M | $48.9M | $49.5M | $46.8M | $43.7M | |
| Other Inc / (Exp) | -$2.7M | -$666K | $535K | -$859K | -$2.2M | |
| Operating Expenses | $57.8M | $65.6M | $68M | $64.2M | $61M | |
| Operating Income | $221K | $2.1M | -$7.2M | $1.9M | -$6.2M | |
| Net Interest Expenses | $4.8M | $1.5M | $2.5M | $3.6M | $3.2M | |
| EBT. Incl. Unusual Items | -$7.3M | -$140K | -$9.2M | -$2.6M | -$11.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $518K | $148K | $337K | $859K | $740K | |
| Net Income to Company | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Basic EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Weighted Average Basic Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| Weighted Average Diluted Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| EBITDA | $5.2M | $9M | $944K | $8M | -$1.3M | |
| EBIT | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Revenue (Reported) | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Operating Income (Reported) | $221K | $2.1M | -$7.2M | $1.9M | -$6.2M | |
| Operating Income (Adjusted) | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31M | $33.1M | $28.4M | $28.2M | $24.6M | |
| Revenue Growth (YoY) | 0.04% | 6.68% | -14% | -0.96% | -12.78% | |
| Cost of Revenues | $13.3M | $13.5M | $12.6M | $11.8M | $10.5M | |
| Gross Profit | $17.7M | $19.6M | $15.8M | $16.3M | $14M | |
| Gross Profit Margin | 57.15% | 59.17% | 55.7% | 57.99% | 57.06% | |
| R&D Expenses | $2.3M | $3M | $2.8M | $3.2M | $2.3M | |
| Selling, General & Admin | $11.2M | $13.5M | $11.8M | $11.4M | $10.2M | |
| Other Inc / (Exp) | -$2.2M | -$189K | $465K | -$591K | $2.8M | |
| Operating Expenses | $15M | $17.9M | $16.3M | $16M | $15.4M | |
| Operating Income | $2.8M | $1.7M | -$457K | $282K | -$1.4M | |
| Net Interest Expenses | $1.1M | $379K | $900K | $794K | $853K | |
| EBT. Incl. Unusual Items | -$548K | $1.1M | -$892K | -$1.1M | $590K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $67K | $170K | $774K | $715K | $572K | |
| Net Income to Company | -$615K | $961K | -$1.7M | -$1.8M | $18K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$615K | $961K | -$1.7M | -$1.8M | $18K | |
| Basic EPS (Cont. Ops) | -$0.02 | $0.02 | -$0.04 | -$0.04 | -- | |
| Diluted EPS (Cont. Ops) | -$0.02 | $0.02 | -$0.04 | -$0.04 | -- | |
| Weighted Average Basic Share | $38.9M | $40.8M | $41.6M | $42.6M | $43.7M | |
| Weighted Average Diluted Share | $38.9M | $40.8M | $41.6M | $42.6M | $43.7M | |
| EBITDA | $2.5M | $3.4M | $2M | $1.5M | $3.2M | |
| EBIT | $546K | $1.5M | $8K | -$309K | $1.4M | |
| Revenue (Reported) | $31M | $33.1M | $28.4M | $28.2M | $24.6M | |
| Operating Income (Reported) | $2.8M | $1.7M | -$457K | $282K | -$1.4M | |
| Operating Income (Adjusted) | $546K | $1.5M | $8K | -$309K | $1.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.1M | $51.3M | $52.5M | $46.2M | $39.4M | |
| Gross Profit | $58M | $67.7M | $60.8M | $66.1M | $54.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | |
| Selling, General & Admin | $43.4M | $48.9M | $49.5M | $46.8M | $43.7M | |
| Other Inc / (Exp) | -$2.7M | -$666K | $535K | -$859K | -$1.3M | |
| Operating Expenses | $57.8M | $65.6M | $68M | $64.2M | $61.9M | |
| Operating Income | $221K | $2.1M | -$7.2M | $1.9M | -$7.2M | |
| Net Interest Expenses | $4.8M | $1.5M | $2.5M | $3.6M | $3.2M | |
| EBT. Incl. Unusual Items | -$7.3M | -$140K | -$9.2M | -$2.6M | -$11.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $518K | $148K | $337K | $859K | $740K | |
| Net Income to Company | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Basic EPS (Cont. Ops) | -$0.21 | -$0.01 | -$0.23 | -$0.08 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.21 | -$0.01 | -$0.23 | -$0.08 | -$0.29 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $5.2M | $9M | $944K | $8M | -$1.3M | |
| EBIT | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Revenue (Reported) | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Operating Income (Reported) | $221K | $2.1M | -$7.2M | $1.9M | -$7.2M | |
| Operating Income (Adjusted) | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $118.9M | $113.3M | $112.3M | $94.1M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $51.3M | $52.5M | $46.2M | $39.4M | -- | |
| Gross Profit | $67.7M | $60.8M | $66.1M | $54.8M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.8M | $12.3M | $11.8M | $10.4M | -- | |
| Selling, General & Admin | $48.9M | $49.5M | $46.8M | $43.7M | -- | |
| Other Inc / (Exp) | -$666K | $535K | -$859K | -$1.3M | -- | |
| Operating Expenses | $65.6M | $68M | $64.2M | $61.9M | -- | |
| Operating Income | $2.1M | -$7.2M | $1.9M | -$7.2M | -- | |
| Net Interest Expenses | $1.5M | $2.5M | $3.6M | $3.2M | -- | |
| EBT. Incl. Unusual Items | -$140K | -$9.2M | -$2.6M | -$11.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $148K | $337K | $859K | $740K | -- | |
| Net Income to Company | -$288K | -$9.5M | -$3.4M | -$12.4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$288K | -$9.5M | -$3.4M | -$12.4M | -- | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.23 | -$0.08 | -$0.29 | -- | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.23 | -$0.08 | -$0.29 | -- | |
| Weighted Average Basic Share | $161.5M | $165.8M | $169.8M | $174.2M | -- | |
| Weighted Average Diluted Share | $161.5M | $167M | $170.5M | $174.2M | -- | |
| EBITDA | $9M | $944K | $8M | -$1.3M | -- | |
| EBIT | $1.4M | -$6.6M | $1M | -$8.5M | -- | |
| Revenue (Reported) | $118.9M | $113.3M | $112.3M | $94.1M | -- | |
| Operating Income (Reported) | $2.1M | -$7.2M | $1.9M | -$7.2M | -- | |
| Operating Income (Adjusted) | $1.4M | -$6.6M | $1M | -$8.5M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $17.8M | $21.8M | $16.7M | $16.1M | $14.9M | |
| Inventory | $22.3M | $27.6M | $26.4M | $24.7M | $23.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.4M | $4.3M | $3.5M | $3.9M | $2.9M | |
| Total Current Assets | $51.7M | $61.6M | $51.1M | $49M | $45.1M | |
| Property Plant And Equipment | $11.7M | $10.3M | $9.2M | $8.8M | $11.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58.6M | $57.7M | $56.3M | $57.1M | $56.3M | |
| Other Intangibles | $33.2M | $27.4M | $21M | $16M | $11.1M | |
| Other Long-Term Assets | $1.1M | $5.4M | $7.8M | $6.5M | $2.8M | |
| Total Assets | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Accounts Payable | $6M | $4.9M | $6.4M | $5.6M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $3.2M | $3.8M | $5.9M | $37M | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.1M | $2.1M | $1.4M | $1.2M | |
| Other Current Liabilities | $3.3M | $4.3M | $4M | $5.3M | $6.5M | |
| Total Current Liabilities | $21.1M | $25.3M | $23.2M | $26.5M | $55M | |
| Long-Term Debt | $46.3M | $45.1M | $43M | $30.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.6M | $78.9M | $73.1M | $64.3M | $63.3M | |
| Common Stock | $444K | $452K | $454K | $434K | $441K | |
| Other Common Equity Adj | -$13.1M | -$10M | -$15.1M | -$14.2M | -$15.7M | |
| Common Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Liabilities and Equity | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Cash and Short Terms | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Total Debt | $48M | $48.3M | $46.8M | $36.6M | $37M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $17.8M | $21.8M | $16.7M | $16.1M | $14.9M | |
| Inventory | $22.3M | $27.6M | $26.4M | $24.7M | $23.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.4M | $4.3M | $3.5M | $3.9M | $2.9M | |
| Total Current Assets | $51.7M | $61.6M | $51.1M | $49M | $45.1M | |
| Property Plant And Equipment | $11.7M | $10.3M | $9.2M | $8.8M | $11.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58.6M | $57.7M | $56.3M | $57.1M | $56.3M | |
| Other Intangibles | $33.2M | $27.4M | $21M | $16M | $11.1M | |
| Other Long-Term Assets | $1.1M | $5.4M | $7.8M | $6.5M | $2.8M | |
| Total Assets | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Accounts Payable | $6M | $4.9M | $6.4M | $5.6M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $3.2M | $3.8M | $5.9M | $37M | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.1M | $2.1M | $1.4M | $1.2M | |
| Other Current Liabilities | $3.3M | $4.3M | $4M | $5.3M | $6.5M | |
| Total Current Liabilities | $21.1M | $25.3M | $23.2M | $26.5M | $55M | |
| Long-Term Debt | $46.3M | $45.1M | $43M | $30.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.6M | $78.9M | $73.1M | $64.3M | $63.3M | |
| Common Stock | $444K | $452K | $454K | $434K | $441K | |
| Other Common Equity Adj | -$13.1M | -$10M | -$15.1M | -$14.2M | -$15.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Liabilities and Equity | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Cash and Short Terms | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Total Debt | $48M | $48.3M | $46.8M | $36.6M | $37M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7.6M | $7M | $7.2M | |
| Stock-Based Compensation | $3.6M | $4.2M | $4.4M | $5M | $4.3M | |
| Change in Accounts Receivable | $3.1M | -$4.3M | $4.8M | $810K | $974K | |
| Change in Inventories | $413K | -$5.9M | $252K | $1.5M | -$64K | |
| Cash From Operations | $9.3M | $1.3M | $1.2M | $14M | $1.4M | |
| Capital Expenditures | $1.4M | $1.3M | $1.6M | $2.3M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | $512K | -- | |
| Cash From Investing | -$1.4M | -$1.3M | -$1.6M | -$1.8M | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $61.3M | $4.3M | $7.8M | $4.5M | $8.8M | |
| Long-Term Debt Repaid | -$66.9M | -$4.2M | -$9.6M | -$15M | -$8.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | -$3.6M | -$1.6M | -$2.5M | -$738K | |
| Cash From Financing | -$8M | -$252K | -$2.8M | -$12.1M | -$131K | |
| Beginning Cash (CF) | $8.3M | $8.3M | $7.8M | $4.5M | $4.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38K | -$335K | -$3.3M | $95K | -$35K | |
| Ending Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Levered Free Cash Flow | $7.9M | -$83K | -$438K | $11.7M | -$1.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$615K | $961K | -$1.7M | -$1.8M | $18K | |
| Depreciation & Amoritzation | $1.9M | $1.9M | $2M | $1.8M | $1.8M | |
| Stock-Based Compensation | $1M | $1M | $1M | $1.4M | $961K | |
| Change in Accounts Receivable | -$3.7M | -$3.6M | -$1.3M | -$941K | -$2.3M | |
| Change in Inventories | $924K | -$1.8M | $581K | $1.4M | $2.4M | |
| Cash From Operations | $2.5M | $117K | $2.7M | $4.3M | $1.7M | |
| Capital Expenditures | $314K | $358K | $235K | $1.1M | $466K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$314K | -$358K | -$235K | -$1.1M | -$466K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $51.7M | $1.8M | -- | $1M | -- | |
| Long-Term Debt Repaid | -$46.7M | $1.3M | -$2.5M | -$3.3M | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.2M | -$861K | -$461K | -$2.1M | -$518K | |
| Cash From Financing | $3.4M | $2.6M | -$2.7M | -$4.1M | -$1.4M | |
| Beginning Cash (CF) | $2.8M | $5.5M | $5.1M | $5.3M | $4.6M | |
| Foreign Exchange Rate Adjustment | -$22K | -$80K | -$350K | -$183K | -$363K | |
| Additions / Reductions | $5.5M | $2.4M | -$286K | -$874K | -$98K | |
| Ending Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Levered Free Cash Flow | $2.2M | -$241K | $2.4M | $3.2M | $1.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7.6M | $7M | $7.2M | |
| Stock-Based Compensation | $3.6M | $4.2M | $4.4M | $5M | $4.3M | |
| Change in Accounts Receivable | $3.1M | -$4.3M | $4.8M | $810K | $974K | |
| Change in Inventories | $413K | -$5.9M | $252K | $1.5M | -$64K | |
| Cash From Operations | $9.3M | $1.3M | $1.2M | $14M | $1.4M | |
| Capital Expenditures | $1.4M | $1.3M | $1.6M | $2.3M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | $512K | -- | |
| Cash From Investing | -$1.4M | -$1.3M | -$1.6M | -$1.8M | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $4.3M | $7.8M | $4.5M | $8.8M | |
| Long-Term Debt Repaid | -$66.9M | -$4.2M | -$9.6M | -$15M | -$8.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | -$3.6M | -$1.6M | -$2.5M | -$738K | |
| Cash From Financing | -$8M | -$252K | -$2.8M | -$12.1M | -$131K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38K | -$335K | -$3.3M | $95K | -$35K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.9M | -$83K | -$438K | $11.7M | -$1.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$288K | -$9.5M | -$3.4M | -$12.4M | -- | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7M | $7.2M | -- | |
| Stock-Based Compensation | $4.2M | $4.4M | $5M | $4.3M | -- | |
| Change in Accounts Receivable | -$4.3M | $4.8M | $810K | $974K | -- | |
| Change in Inventories | -$5.9M | $252K | $1.5M | -$64K | -- | |
| Cash From Operations | $1.3M | $1.2M | $14M | $1.4M | -- | |
| Capital Expenditures | $1.3M | $1.6M | $2.3M | $3.3M | -- | |
| Cash Acquisitions | -- | -- | $512K | -- | -- | |
| Cash From Investing | -$1.3M | -$1.6M | -$1.8M | -$1.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.3M | $7.8M | $4.5M | $8.8M | -- | |
| Long-Term Debt Repaid | -$4.2M | -$9.6M | -$15M | -$8.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.6M | -$1.6M | -$2.5M | -$738K | -- | |
| Cash From Financing | -$252K | -$2.8M | -$12.1M | -$131K | -- | |
| Beginning Cash (CF) | $25.9M | $22.7M | $18M | $17.2M | -- | |
| Foreign Exchange Rate Adjustment | -$161K | -$38K | -$320K | -$140K | -- | |
| Additions / Reductions | -$335K | -$3.3M | $95K | -$35K | -- | |
| Ending Cash (CF) | $25.4M | $19.3M | $17.7M | $17M | -- | |
| Levered Free Cash Flow | -$83K | -$438K | $11.7M | -$1.8M | -- | |
Get HBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HBIO
Sector
P/E ratio
--
23.02x
PEG ratio
0.00x
0.00x
P/B ratio
0.25x
1.55x
Price / LTM sales
0.17x
1.59x
Growth Metrics
HBIO
Sector
Revenue growth
-12.78%
6.4%
Earnings growth
--
8.33%
Revenue (5-year growth)
-4.12%
8.25%
Earnings forecast
-$0.04
-$0.19
Profitability
HBIO
Sector
Profitability FY 2024
$54.8M
$54.8M
Return on invested capital
-11.92%
-14.83%
Return on assets
-9.44%
-11.9%
Return on equity
-18.36%
-17.27%
Earnings Date
Last Earnings Date
Mar
12
Next Earnings Date
May
7
Estimated Next Earnings Date
Jun
11
Balance Sheet
HBIO
Sector
Total cash
$4.1M
$40.5M
Short term investments
--
$36.1M
Total assets
$126.6M
$122.5M
Long term debt
$37M
$9.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
